Cargando…
Oncogenic driver mutations in non-small cell lung cancer: Past, present and future
Lung cancer, of which non-small lung cancer is the most common subtype, represents the leading cause of cancer related-death worldwide. It is now recognized that a significant proportion of these patients present alterations in certain genes that drive oncogenesis. In recent years, more of these so-...
Autores principales: | Chevallier, Mathieu, Borgeaud, Maxime, Addeo, Alfredo, Friedlaender, Alex |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8085514/ https://www.ncbi.nlm.nih.gov/pubmed/33959476 http://dx.doi.org/10.5306/wjco.v12.i4.217 |
Ejemplares similares
-
The Impact of Variant Allele Frequency in EGFR Mutated NSCLC Patients on Targeted Therapy
por: Friedlaender, Alex, et al.
Publicado: (2021) -
Vertebral Metastasis Treated by Vertebroplasty, a Cause of Respiratory Failure: Case Report and Literature Review
por: Chevallier, Mathieu, et al.
Publicado: (2021) -
Evolving Therapeutic Scenario of Stage III Non-Small-Cell Lung
Cancer
por: Baudoux, Nathalie, et al.
Publicado: (2023) -
Pleural Mesothelioma in the Era of Immunotherapy
por: Chevallier, Mathieu, et al.
Publicado: (2023) -
The Evolving Role of Immune-Checkpoint Inhibitors in Malignant Pleural Mesothelioma
por: Borgeaud, Maxime, et al.
Publicado: (2023)